Asbestos exposure, 8-izoprostane and leukotriens in exhaled breath condensate

D. Pelclová, Z. Fenclová, P. Kacer, M. Kuzma, J. Lebedová, T. Navrátil, P. Klusácková (Prague, Czech Republic)

Source: Annual Congress 2006 - Inorganic dusts
Session: Inorganic dusts
Session type: Thematic Poster Session
Number: 4016
Disease area: Airway diseases, Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. Pelclová, Z. Fenclová, P. Kacer, M. Kuzma, J. Lebedová, T. Navrátil, P. Klusácková (Prague, Czech Republic). Asbestos exposure, 8-izoprostane and leukotriens in exhaled breath condensate. Eur Respir J 2006; 28: Suppl. 50, 4016

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Keratin detected in exhaled breath condensate is an environmental contaminant
Source: Annual Congress 2005 - Airway epithelial cells in asthma and COPD
Year: 2005


8-isoprostane in exhaled breath condensate (EBC) and air pollution exposure in children with wheezing
Source: Annual Congress 2012 - Indoor and outdoor air pollution
Year: 2012

Exhaled breath condensate total NOx in chronic lung disease in response to changes in ambient air pollution
Source: Annual Congress 2007 - What's new in air pollution from experiments to epidemiology
Year: 2007



Monitoring of 24-hours variation of leukotrienes in exhaled breath condensate
Source: Annual Congress 2007 - Acute and chronic effects of air pollution
Year: 2007


Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate
Source: Eur Respir J 2006; 28: 1036-1041
Year: 2006



Exhaled breath condensate
Source: Annual Congress 2003 - PG18 - Markers of inflammation in obstructive airway disease
Year: 2003

Methodology of exhaled breath condensate
Source: Annual Congress 2009 - Noninvasive monitoring of airway inflammation: beyond exhaled nitric oxide
Year: 2009


Separate lung exhaled breath condensate collection confirms intrapulmonary origin of exhaled breath condensate acidification
Source: Eur Respir J 2007; 30: Suppl. 51, 364s
Year: 2007

Exhaled breath condensate: metabolomics
Source: Eur Respir Monogr 2010; 49: 231-236
Year: 2010


Endogenous and exogenous metabolites in exhaled breath condensate in asthma
Source: Annual Congress 2012 - Exhaled biomarkers in airway diseases
Year: 2012

Parameters of oxidation in exhaled breath condensate
Source: Eur Respir J 2004; 24: Suppl. 48, 470s
Year: 2004

Correlation of LTB4 with α-amylase in exhaled breath condensate
Source: Eur Respir J 2005; 26: Suppl. 49, 372s
Year: 2005

Exhaled breath condensate: 8-isoprostane and eicosanoids
Source: Eur Respir Monogr 2010; 49: 196-206
Year: 2010


Leukotrienes in exhaled breath condensate in childhood asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 398s
Year: 2003

Structures of an exhaled breath condensate in lung diseases
Source: Eur Respir J 2005; 26: Suppl. 49, 525s
Year: 2005

Exhaled breath condensate contains more than only volatiles
Source: Eur Respir J 2003; 22: 187-188
Year: 2003


Exhaled breath condensate pH standardised for CO2 partial pressure
Source: Eur Respir J 2007; 29: 496-501
Year: 2007



Biomarkers of oxidative stress in exhaled breath condensate following ozone exposure in volunteers
Source: Eur Respir J 2001; 18: Suppl. 33, 460s
Year: 2001

Increased 8-isoprostane in the exhaled breath condensate of down patients
Source: Eur Respir J 2004; 24: Suppl. 48, 556s
Year: 2004